END-STAGE RENAL DISEASE
Clinical trials for END-STAGE RENAL DISEASE explained in plain language.
Never miss a new study
Get alerted when new END-STAGE RENAL DISEASE trials appear
Sign up with your email to follow new studies for END-STAGE RENAL DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kidney patients with Hard-to-Match immune systems
Disease control TerminatedThis study tested two drugs, daratumumab and belatacept, in 5 highly sensitized dialysis patients waiting for a kidney transplant. The goal was to safely reduce the antibodies that make it very hard to find a compatible donor kidney. The trial was stopped early, but it aimed to h…
Matched conditions: END-STAGE RENAL DISEASE
Phase: PHASE2 • Sponsor: University Hospital, Grenoble • Aim: Disease control
Last updated Jun 15, 2026 19:03 UTC
-
Dialysis showdown: which type helps kidney patients live longer?
Knowledge-focused TerminatedThis study compared survival rates between two common dialysis methods—peritoneal dialysis and hemodialysis—in 416 adults with end-stage kidney disease in China. Researchers tracked deaths, complications, and quality of life to see if one method offered better outcomes. The study…
Matched conditions: END-STAGE RENAL DISEASE
Phase: NA • Sponsor: Vantive Health LLC • Aim: Knowledge-focused
Last updated Jun 15, 2026 19:03 UTC